What is Evereden?
Founded in 2018 and headquartered in New York, Evereden operates within the consumer goods sector, specifically focusing on manufacturing and retailing a comprehensive range of skincare products for women and children. Their product line spans from essential items like diaper creams to specialized treatments such as stretch mark lotions, catering to a niche market within the broader beauty and personal care industry.
How much funding has Evereden raised?
Evereden has raised a total of $32M across 1 funding round:
Series C
$32M
Series C (2021): $32M with participation from GSR Ventures
Key Investors in Evereden
GSR Ventures
GSR Ventures is a venture capital firm that typically invests in early-stage technology companies, though their participation in Evereden's Series C round suggests a broader investment thesis or a strategic interest in the consumer goods sector.
What's next for Evereden?
The substantial enterprise-level funding Evereden has attracted, particularly the recent Series C investment, positions the company for accelerated expansion and market penetration. This capital infusion is likely to fuel advancements in product development, enhance manufacturing capabilities, and broaden distribution channels. The strategic nature of the recent financing suggests a focus on strengthening its market position and potentially exploring new product categories or demographic segments within the women's and children's wellness space. Future growth may involve scaling operations, increasing brand visibility through targeted marketing campaigns, and solidifying its reputation as a trusted provider of specialized skincare solutions.
See full Evereden company page
